| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/15/2007 | CA2614156A1 Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents |
| 02/15/2007 | CA2611389A1 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 02/15/2007 | CA2583274A1 Enhancement of b cell proliferation by il-15 |
| 02/14/2007 | EP1752538A1 Human bikunin |
| 02/14/2007 | EP1752536A1 Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same |
| 02/14/2007 | EP1752457A1 Fused heterocyclic compound |
| 02/14/2007 | EP1752452A1 Propane-1,3-dione derivative or its salt |
| 02/14/2007 | EP1752446A2 Compounds for modulating cell proliferation |
| 02/14/2007 | EP1752160A2 Epitope sequences |
| 02/14/2007 | EP1752150A1 Irinotecan preparation |
| 02/14/2007 | EP1752148A2 Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease |
| 02/14/2007 | EP1751554A1 Method for screening and compositions for treating cancers |
| 02/14/2007 | EP1751191A2 Antibodies to angiogenesis inhibiting domains of cd148 |
| 02/14/2007 | EP1751183A2 Fas associated factor 1 |
| 02/14/2007 | EP1751172A1 Novel 3-triazolyl-galactoside inhibitors of galectins |
| 02/14/2007 | EP1751171A1 Novel galactoside inhibitors of galectins |
| 02/14/2007 | EP1751159A2 Purine derivatives as a1 adenosine receptor antagonists |
| 02/14/2007 | EP1751143A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/14/2007 | EP1751142A1 Pyrimidines derivatives for the treatment of abnormal cell growth |
| 02/14/2007 | EP1751141A1 Novel pyridazinone derivatives as inhibitors of cdk2 |
| 02/14/2007 | EP1751133A2 Compositions useful as inhibitors of rock and other protein kinases |
| 02/14/2007 | EP1751128A1 Chromene-derivatives with anti-tubulin and vascular targeting activity |
| 02/14/2007 | EP1751121A2 Process for the preparation of anastrozole |
| 02/14/2007 | EP1751119A1 Novel fused heterocycles and uses thereof |
| 02/14/2007 | EP1751118A1 Pyrimidines for use as plk inhibitors |
| 02/14/2007 | EP1751094A2 Beta-peptides |
| 02/14/2007 | EP1750764A2 Antibodies of angiogenesis inhibiting domains of cd148 |
| 02/14/2007 | EP1750763A1 Method to reduce hepatotoxicity of fas-mediated apoptosis-inducing agents |
| 02/14/2007 | EP1750748A1 Use of the foamy virus bet protein for inactivating apobec |
| 02/14/2007 | EP1750735A1 Use of an aloysia/verbrena/lippia triphylla/citridora for treating chronic and /or inflammatory diseases |
| 02/14/2007 | EP1750732A2 Cancer cell growth inhibition by black bean (phaseolus vulgarisl) extracts |
| 02/14/2007 | EP1750716A1 Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin |
| 02/14/2007 | EP1750714A1 Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis |
| 02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/14/2007 | EP1750703A1 Method for reducing gastrointestinal toxicity due to the administration of tegafur |
| 02/14/2007 | EP1750692A2 Method of tonic treatment with oxyphenbutazone derivatives |
| 02/14/2007 | EP1750690A1 Use of targeted oxidative therapeutic formulation in treatment of cancer |
| 02/14/2007 | EP1750687A2 Indole and azaindole derivatives with antitumor action |
| 02/14/2007 | EP1687013B1 Drug, comprising prunus armenica, cocos nucifera and humulus lupulus |
| 02/14/2007 | EP1670782B1 Quinazoline derivatives |
| 02/14/2007 | EP1583523B1 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments |
| 02/14/2007 | EP1560828B9 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 02/14/2007 | EP1523485B1 3-furanyl analogs of toxoflavine as kinase inhibitors |
| 02/14/2007 | EP1507514B1 Controlled release compositions of estradiol metabolites |
| 02/14/2007 | EP1496909B1 Combination therapy for the treatment of cancer |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1370552B1 Rho-kinase inhibitors |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP1341790B1 Sulfonamido ether substituted imidazoquinolines |
| 02/14/2007 | EP1294715B1 Quinazoline ditosylate salt compounds |
| 02/14/2007 | EP1280515B1 Pharmaceutical compositions comprising cannabis |
| 02/14/2007 | EP1278763B1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 02/14/2007 | EP1259234B9 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 02/14/2007 | EP1200458B1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/14/2007 | EP1171144B1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa |
| 02/14/2007 | EP1140147B1 hCG THERAPY FOR THE TREATMENT OF METASTATIC BREAST CANCER |
| 02/14/2007 | EP1128813B1 An inhalation system |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | EP0820283B1 Lactacystin analogs |
| 02/14/2007 | CN1914335A Antisense oligonucleotide modulation of STAT3 expression |
| 02/14/2007 | CN1914191A Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 02/14/2007 | CN1914187A Crystalline polymorphs of a CXC-chemokine receptor ligand |
| 02/14/2007 | CN1913884A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
| 02/14/2007 | CN1912111A Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
| 02/14/2007 | CN1911965A Binding domain-immunoglobulin fusion proteins |
| 02/14/2007 | CN1911933A Oxygen, nitrogen heterocyclic naphthoyl imine kind compound and its bioapplication |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911927A Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf alpha levels |
| 02/14/2007 | CN1911449A Cholesterol phosphononucleoside analogue |
| 02/14/2007 | CN1911447A Transferrin-polyethylene glycol medicine molecular compound and its use |
| 02/14/2007 | CN1911446A Process for producing nanoparticles of paclitaxel and albumin |
| 02/14/2007 | CN1911443A Vaccine composition comprising tumor antigen and adjunvant composition |
| 02/14/2007 | CN1911440A Kit used for forming fiber protein film and its application |
| 02/14/2007 | CN1911402A Medicated liquid for male to health-preserving and prolonging life |
| 02/14/2007 | CN1911354A Medicated liquid for female health preserving and prolonging life |
| 02/14/2007 | CN1911340A Traditional Chinese medicine for treating cancer |
| 02/14/2007 | CN1911329A Traditional Chinese medicine composition for preventing and/or adjuvant therapy of malignant tumor |
| 02/14/2007 | CN1911314A Plant extractive and its prepn. method |
| 02/14/2007 | CN1911277A Medicine for treating leukopenia |
| 02/14/2007 | CN1911276A Medicine for treating blood system disease |
| 02/14/2007 | CN1911270A Traditional Chinese medicine contg. herbalycopic active component for anti-tumor and anti-oxidation, its prepn. method and use |
| 02/14/2007 | CN1911266A Medicated composition contg. Brazil mushroom, Baifeng bean, and its prepn. method |
| 02/14/2007 | CN1911265A Composite medicine contg. Brazil mushroom, Baifeng bean and pearl micro-particle powder |
| 02/14/2007 | CN1911258A Extractive of parasitic loranthus, prepn. method and application thereof |
| 02/14/2007 | CN1911243A Method for preparing platinum metal bunch with biological activity, and use thereof |
| 02/14/2007 | CN1911242A Carried-type active platinum metal bunch, prepn. method and use thereof |
| 02/14/2007 | CN1911234A Reversing agent for drug-fast during treating tumor with multiple medicines |
| 02/14/2007 | CN1911221A Use of a hypoglycemic agent for treating impaired glucose metabolism |
| 02/14/2007 | CN1911218A Combinations comprising epothilones and pharmaceutical uses thereof |
| 02/14/2007 | CN1911215A Application of gossypol and its derivatives for preparing medicine for treating leukemia |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/14/2007 | CN1300160C Fatty acid ester compounds of ginsenoside secondary glycoside compound K and method for preparing same |
| 02/14/2007 | CN1300158C Non-natural active oligosaccharide compounds, preparing process and application |
| 02/14/2007 | CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
| 02/14/2007 | CN1300143C Temozolomide refining process |
| 02/14/2007 | CN1300129C Compound of 3,15-dicarbonyl erythro mildew acid kind and its ester and salt |
| 02/14/2007 | CN1300118C Preparation method of 4-(3-chlor-4-fluorobenzeneamidocyanogen)-7-methoxy-6-(3-morpholine oxypropyl)quinazoline |